---
title: "Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295013021.md"
description: "Regeneron Pharmaceuticals (REGN) shares rose 1.04% to $768.58 on Wednesday, marking its second consecutive day of gains. However, the stock underperformed compared to competitors like Amgen, which surged 4.57%. Trading volume remained significantly below the 50-day average. Despite the daily increase, Regeneron closed 6.40% below its 52-week high reached in January."
datetime: "2026-08-05T20:45:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295013021.md)
  - [en](https://longbridge.com/en/news/295013021.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295013021.md)
---

# Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) rose 1.04% to $768.58 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.49% to 54,349.12 and the S&P 500 Index falling 0.17% to 7,723.55.

This was the stock's second consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 6.40% below its 52-week high of $821.11, which the company reached on January 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. (AMGN) rose 4.57% to $407.83, Moderna Inc. (MRNA) fell 1.29% to $56.26, and Gilead Sciences Inc. (GILD) fell 2.58% to $131.76.

Trading volume (529,809) remained 465,545 below its 50-day average volume of 995,354.

Data source: Dow Jones Market Data, FactSet. Data compiled August 5, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-05-26 1645ET

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [If You Invested $1000 In Regeneron Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/295958013.md)
- [12:50 ETREGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt](https://longbridge.com/en/news/295826897.md)
- [USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296020218.md)
- [15:34 ETRegeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman](https://longbridge.com/en/news/295967459.md)
- [NewEdge Advisors LLC Has $5.88 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/295508474.md)